A Randomized, Double-blind, Placebo-controlled Phase II Multi-Centre Evaluation to Assess the Safety and Tolerability of DM199 Administered Intravenously and Subcutaneously in Subjects with Acute Ischemic Stroke (ReMEDy Trial).
- Cloud, Geoffrey (Primary Chief Investigator (PCI))
Project: Research